Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device
-
Stellar Line-up at Qlik Connect 2024 Charts Future of Data and AI
-
Rackspace Technology Appoints Experienced and Seasoned Executive Mark Gross to Board of Directors
-
MGP Ingredients Schedules Fourth Quarter and Full Year 2023 Conference Call/Webcast for Thursday, February 22
-
Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients
-
Issue of Equity
-
Forbes Names Demio “Best Webinar Tool for Marketers”
-
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
-
Man Group PLC : Form 8.3 - Barrat Developments plc
-
Solera Announces Leadership Transition
-
Blink Charging Chosen by City of Frederick, Maryland, for Downtown Electric Vehicle Charging Solutions
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
NFI Announces Chief Financial Officer Transition
-
Stronghold Announces January Bitcoin Mining and Carbon Capture Update
-
Nexterus Emcees Panel of Supply Chain Executives discussing “Navigating the Complexities of Global Supply Chains”
-
Palisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion Leaders
-
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
-
Majority of Ontarians wagering on Super Bowl LVIII to bet online
-
Microchip Earns Certification in ISO/SAE 21434 Road Vehicle—Cybersecurity Engineering Standard from UL Solutions
-
Harfang Acquires 100% Interest in the Egan Gold Property
-
Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
-
Tenaya Therapeutics Announces Pricing of Underwritten Offering
-
Replimune Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
-
HUB Cyber Security and Blackswan Tech Team Up for $3.2M Deal with a Top-Tier European Bank
-
Mineralys Therapeutics Announces $120 Million Private Placement Financing
-
Madrigal Pharmaceuticals Announces Publication of the Phase 3 MAESTRO-NASH Trial of Resmetirom in the New England Journal of Medicine
-
Refined Metals Corp. Announces Change to Executive Management
-
Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders
-
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination Product
-
authID Positions for Strong Growth in Biometric Identity Verification and Authentication with New Identity Domain Talent
-
Pixalate Introduces Top Sell-Side Platforms (SSPs) For Inventory Quality for Asia-Pacific (APAC), Europe, Middle East and Africa (EMEA), Latin America (LATAM), and North America Regions in Q4 2023 Glo
-
iManage Announces New Total Economic Impact (TEI) Study, Documenting Benefits of iManage Platform to Enterprise Customers
-
Asia Broadband Poised For High Growth in 2024 From Major Advances In Mining Operations
-
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Synthetic Mescaline Protocol
-
JumpCloud Wins 2024 G2 ‘Best of’ Software Awards
-
Kobiton Open-Sources Appium Script Generation Tool
-
Auron Selects First Development Candidate for its Portfolio of Next-Generation Targeted Cancer Treatments from its Novel AURIGIN™ Platform
-
CMC's Strategic Incubation of Galaxis Unveiled: A New Era for Blockchain-Powered Communities
-
Nasdaq Private Market Closes $62.4 Million Series B Financing, Led by Nasdaq, with New Investments from BNP Paribas, DRW Venture Capital, UBS, and Wells Fargo
-
Ubiquitech Software Corp. (OTC: UBQU) Unveils Groundbreaking Lifestyle Video Marketing Initiative for Innovative Outcomes Driving Rapid Company Growth
-
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
-
Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magovčević-Liebisch, Ph.D., J.D., to Board of Directors
-
Biora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease Symposium
-
Tyton Partners’ ‘Investing in Tomorrow’ Research Reveals a $100,000 Per Student Impact of High School Financial Education
-
The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access
-
Healthwise Ranked #1 in Patient Education in 2024 Best in KLAS Report
-
AgEagle Secures Major Contract for eBee X and eBee TAC Drones for Use by U.S. Department of Energy Laboratory
-
Assembly Biosciences Announces Effective Date of Reverse Stock Split
-
Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time
-
Park Place Technologies Announces Inaugural 2023 Channel Partner Awards Recipients
